Natera Inc. (NTRA)
NTRA · Health Care · 
United States
Natera Inc. (NTRA) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 0.89%. Anyone who holds an ETF containing Natera also has an indirect stake in the company.
Data and Charts: Natera
Key Data for Natera
Natera Stock Price Chart
The Natera chart shows daily closing prices and is set to the current year by default. The stock is up 80.8% year to date and up 114.4% over twelve months. The last recorded close on October 30, 2026, was $414.30, at 91% of the 52-week range.
Price series from our database since Aug 12, 2024, 558 daily values.
Natera Stock Performance
| Year to date | +80.8% | 1 year | +114.4% |
|---|---|---|---|
| 1 month | +0.2% | 3 months | +54.7% |
| Calendar year 2025 | +44.7% |
Measured in euros, Natera is up 90.2% year to date and up 121.7% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: Natera
What ETF Is Natera In?
Natera has above-average ETF coverage and is held by 16 of the 104 ETFs we track, which together follow 7 indices. That puts the stock in more ETFs than 75.8% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XUHL / XUHC | MSCI USA Health Care | 0.89% | €8.86 |
| XDWH | MSCI World Health Care | 0.65% | €6.54 |
| SPFS | MSCI World Health Care | 0.65% | €6.54 |
| XD9U / XD9D | MSCI USA | 0.09% | €0.89 |
| SWWD | MSCI World | 0.07% | €0.70 |
| SPPW | MSCI World | 0.07% | €0.70 |
| XDWD / XDWL | MSCI World | 0.07% | €0.65 |
| EUNL | MSCI World | 0.06% | €0.60 |
| SPYY | MSCI ACWI | 0.06% | €0.58 |
| WIMI | MSCI World IMI | 0.06% | €0.57 |
| IUSQ | MSCI ACWI | 0.05% | €0.50 |
| SPYI / SPSA | MSCI ACWI IMI | 0.04% | €0.42 |
The last column shows how much of €1,000 in one of these funds goes to Natera, based on each fund's latest holdings list.
US-listed ETFs holding Natera (weight per latest SEC filing): ONEQ 0.10%, VTI 0.05%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Natera Weight in iShares Core MSCI World (EUNL) Since 2025
In iShares Core MSCI World (EUNL), Natera had a weight of 0.03% on Mar 31, 2025 and 0.06% on Oct 30, 2026. The fund tracks the MSCI World. Its share peaked at 0.06% on Sep 30, 2026. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Natera overlaps with the rest of a portfolio.
Which Tracked Investors Hold Natera?
Natera is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. Of the 3 tracked managers holding the stock, 2 added and 1 cut.
| Investor | Shares | Value | Quarter |
|---|---|---|---|
| Duquesne Family Office | 3,186,306 | $865M | increased by 122,700 |
| Viking Global Investors | 390,694 | $106M | newly added |
| Bridgewater Associates | 6,136 | $2M | reduced by 19,101 |
As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains.
What Natera Executives and Directors Traded Recently
| Date | Person | Type | Shares | Price |
|---|---|---|---|---|
| Oct 30, 2026 | Brophy Michael Burkes Officer, CHIEF FINANCIAL OFFICER | Sell (plan) | 1,906 | $425.55 |
| Oct 28, 2026 | Brophy Michael Burkes Officer, CHIEF FINANCIAL OFFICER | Sell (plan) | 865 | $426.87 |
| Oct 28, 2026 | Brophy Michael Burkes Officer, CHIEF FINANCIAL OFFICER | Sell (plan) | 313 | $425.32 |
| Oct 28, 2026 | Fesko John Officer, PRESIDENT, CHIEF BUS. OFFICER | Sell (plan) | 898 | $426.34 |
| Oct 28, 2026 | Moshkevich Solomon Officer, PRESIDENT, CLINICALDIAGNOSTICS | Sell (plan) | 1,162 | $426.34 |
| Oct 28, 2026 | RABINOWITZ DANIEL Officer, SEC. AND CHIEF LEGAL OFFICER | Sell (plan) | 968 | $426.34 |
| Oct 28, 2026 | Chapman Steven Leonard Director, Officer, CEO AND PRESIDENT | Sell (plan) | 3,430 | $426.34 |
| Oct 28, 2026 | Brophy Michael Burkes Officer, CHIEF FINANCIAL OFFICER | Sell (plan) | 1,198 | $426.34 |
The table shows open-market purchases and sales reported over the past 90 days. Directors, officers and shareholders owning more than ten percent must report such transactions within two trading days. Awards and option exercises are excluded.
“Plan” means the transaction follows a schedule set up in advance under Rule 10b5-1. Sales consistently outnumber purchases in these filings because a large part of executive pay is granted in shares. For comparison: over the period covered, executives and directors reported sales at 271 of 350 tracked companies and purchases at 32.
Stocks With ETF Exposure Similar to Natera
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| Natera | – | – | +114.4% | 46.7% | -9.0% | +35.9% |
 Insmed Incorporated | 16 | – | -42.0% | 54.9% | -210.5% | +66.7% |
 Medline | 16 | – | – | 43.8% | 4.1% | +11.5% |
| Neurocrine Biosciences | 16 | – | +5.8% | 36.2% | 16.7% | +21.4% |
 Roivant Sciences | 16 | – | +88.5% | 39.4% | -3,629.2% | -71.6% |
 Revolution Medicines | 16 | – | +225.0% | 56.2% | – | – |
 United Therapeutics Corporation | 16 | – | +32.0% | 41.2% | 41.9% | +10.6% |
 Royalty Pharma Plc | 16 | – | +81.9% | 23.4% | 32.4% | +5.1% |
 Boston Scientific Corporation | 16 | – | -58.3% | 30.9% | 14.4% | +19.9% |
These stocks reach a portfolio through largely the same funds as Natera. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: Natera
Natera Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Dec 2023 | 1.1 | -0.4 | -40.2% |
| FY ended Dec 2024 | 1.7 | -0.2 | -11.2% |
| FY ended Dec 2025 | 2.3 | -0.2 | -9.0% |
Technical Analysis: Natera
Natera Risk Metrics
The close on Oct 30, 2026, was 5.0% below the highest close since Aug 12, 2024. That high was reached on Oct 29, 2026. When the S&P 500 rose or fell 1%, Natera moved 1.30% on average in the same direction (past 252 trading days). The correlation of 0.34, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Natera.
What Natera Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| Twilio Inc. Class A | +0.63 | |
| Microchip Technology Incorporated | +0.56 | |
| Coeur Mining Inc. | +0.53 | |
| Atlassian Corp. Class A | +0.50 | |
| IonQ Inc. | +0.50 | |
| C98 | +0.49 | |
| HFT | -0.48 | |
| YB | -0.38 | |
| KGST | -0.37 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.
